SUBSEQUENT EVENTS (Details Narrative) - USD ($) |
6 Months Ended | |||
|---|---|---|---|---|
Jul. 11, 2021 |
Jun. 30, 2021 |
Jun. 30, 2020 |
Aug. 19, 2019 |
|
| Subsequent Event [Line Items] | ||||
| Warrant offering price | $ 1.00 | |||
| Gross proceeds from exercise of warrants | $ 5,408,540 | |||
| Subsequent Event [Member] | ||||
| Subsequent Event [Line Items] | ||||
| Number of shares issued | 46,029,920 | |||
| Warrants to purchase common stock | 23,014,960 | |||
| Warrant offering price | $ 0.869 | |||
| Gross proceeds from exercise of warrants | $ 40,000,000 | |||
| Warrants exercise price | $ 0.81 | |||
| Proceeds from issuance of stock | $ 36,325,000 | |||
| Cash fee equal to gross proceeds | 7.00% | |||
| Management fee equal to gross proceeds | 0.50% | |||
| Placement agent expenses | $ 25,000 | |||
| Legal fee | 50,000 | |||
| Clearing fee | $ 15,950 | |||
| Subsequent Event [Member] | Engagement Letter [Member] | ||||
| Subsequent Event [Line Items] | ||||
| Warrants to purchase common stock | 2,761,795 | |||
| Description for market capitalization | common stock (which represents 6.0% of the Shares sold to investors in the Offering) at an exercise price equal to 125% of the offering price in the offering, or $1.08625 (the “Placement Agent Warrants”). The Placement Agent Warrants are immediately exercisable until the fifth anniversary of the commencement of sales of the offering. | |||
| Offering price | $ 1.08625 | |||
| X | ||||||||||
- Definition Clearing fees. No definition available.
|
| X | ||||||||||
- Definition Description for market capitalization. No definition available.
|
| X | ||||||||||
- Definition Percentage of cash fee equal to gross proceeds. No definition available.
|
| X | ||||||||||
- Definition Percentage of management fee equal to gross proceeds. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. No definition available.
|
| X | ||||||||||
- Definition The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|